[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
Recruiting · NCT07655869 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| [177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma | Recurrent Glioblastoma IDH Wildtype; Recurrent High-Grade Gliomas | Recruiting | Early phase 1 | 2026-06-18 | NCT07655869 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Tiantan Hospital | 307 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 59 |
| Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College | Beijing | China | 6 |